Showing results (51-60 of 73) with videos related to
Sort By:
Pageof 8
Frontiers in Molecular Biosciences|June 16, 2023
Hydroxyurea pharmacokinetics and precision dosing in low-resource settingsLuke R Smart, Mwesige Charles, Kathryn E McElhinney, et al.BMC Medicine|November 16, 2020
AnemoCheck-LRS: an optimized, color-based point-of-care test to identify severe anemia in limited-resource settingsMarina S Perez-Plazola, Erika A Tyburski, Luke R Smart, et al.Plos Neglected Tropical Diseases|August 18, 2017
Increased hepatotoxicity among HIV-infected adults co-infected with Schistosoma mansoni in Tanzania: A cross-sectional studyAmon I Marti, Soledad Colombe, Peter J Masikini, et al.Annals of Hematology|November 18, 2017
Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID studyLuke R Smart, Emmanuela E Ambrose, Kevin C Raphael, et al.The Lancet. Haematology|March 4, 2023
Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trialEmmanuela E Ambrose, Teresa S Latham, Primrose Songoro, et al.Heart (British Cardiac Society)|April 24, 2016
Short-term and long-term cardiovascular risk, metabolic syndrome and HIV in TanzaniaJustin R Kingery, Yona Alfred, Luke R Smart, et al.Pediatric Quality & Safety|September 3, 2021
Improving Discharge Instructions Following a Concussion Diagnosis in the Pediatric Emergency Department: A Pre-post Intervention StudyAaron M Yengo-Kahn, Natalie Hibshman, Michael Bezzerides, et al.The Lancet. Haematology|May 3, 2024
Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trialBanu Aygun, Adam Lane, Luke R Smart, et al.Plos One|June 21, 2019
Very severe anemia and one year mortality outcome after hospitalization in Tanzanian children: A prospective cohort studyNeema Chami, Duncan K Hau, Tulla S Masoza, et al.Trials|September 22, 2023
Prospective identification of variables as outcomes for treatment (PIVOT): study protocol for a randomised, placebo-controlled trial of hydroxyurea for Ghanaian children and adults with haemoglobin SC diseaseLuke R Smart, Catherine I Segbefia, Teresa S Latham, et al.Pageof 8